THE IMPORTANCE OF CHOOSING THE RIGHT INHALER AND DRUG COMBINATION FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Abstract

The main treatment of chronic obstructive pulmonary disease (COPD) is inhaled bronchodilators. Depending on phenotype and severity of COPD, it is important to select not only themost appropriatemedication, start treatment on time, but also choose themost suitable inhaler. Combination of tiotropium/ olodaterol has shown the benefit of improving lung function, reducing symptoms, hyperinflation, increasing physical activity and endurance, reducing exacerbations of COPD, confirmed the safety and better life quality. Respimat® soft mist inhaler is a unique device that provides extremely high deposition of drug particles even in the smallest airways, is environmentally friendly and ensures twenty-four hours acting bronchodilation for patients with COPD.